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8ABSTRACT
INTRODUCTION: Infections have been shown to be associated with preterm birth (PTB). 
Infections have also been linked with other pregnancy outcomes, such as miscarriage (MC), 
pre-eclampsia, and gestational diabetes mellitus (GDM). Some previous studies have revealed 
that periodontal disease, a low-grade infection dominated by Gram-negative anaerobic and 
microaerophilic bacteria, is associated with an increased risk of PTB, as well as with MC and 
pre-eclampsia. However, the results have been inconclusive, and most studies have been 
conducted among women with a low socioeconomic status and a multi-ethnic background. 
Thus, this study was set up to investigate the association between oral health and pregnancy 
complications in a group of Finnish women. The study hypothesis was that pregnancy 
complications are reflected in women’s oral health and the markers of oral health differ 
between at-risk and healthy non-risk parturient women. 
SUBJECTS AND METHODS: We examined 328 Finnish women with singleton births in this 
cross-sectional study. Within 2 days postpartum, the women were examined clinically with 
microbiological and saliva samples for biochemical analyses. The women completed a 
questionnaire about their health- and lifestyle-related behaviors and oral symptoms. 
Information about demographic factors, prenatal care, and medical and obstetrical history was 
obtained from medical records. Chronic diseases, medications, and the number of previous 
pregnancies, including adverse pregnancy outcomes, were recorded. 
RESULTS: Dental health was uniformly good, and of the separate periodontal parameters, 
none predicted PTB. However, oral inflammatory burden index (OIBI), a combination of 
multiple oral infections, was significantly associated with PTB. Urgency-based dental 
treatment was associated with an increased risk of history of miscarriage (HMC), while 
preventive dental treatment was linked to a diminished risk of HMC. Self-reported poor oral 
health showed a positive association with MC. Salivary immunglobulin A (sIgA) was 
associated with GDM and type 1 diabetes mellitus (T1DM) independent of C-reactive protein 
(CRP), but when T1DM women were excluded, sIgA lost its significance. 
9CONCLUSIONS: Combined effects of multiple oral infections were significantly associated 
with PTB among Finnish women with uniformly good dental health. Oral healthcare patterns 
affected birth outcomes and neglectful dental care patterns were associated with a higher 
probability of HMC. Women planning a pregnancy or who are already pregnant should be 
informed about the role of oral health in the course of pregnancy and the welfare of their 
fetus. Women should be referred to oral examination and necessary treatment and counselled 
for preventive oral self-care. 
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ABBREVIATIONS
A.a. Actinobacillus actinomycetemcomitans
ADA American Diabetes Association 
AL Attachment loss 
B.f. Bacterioides forsythus
BMI Body mass index
BOP Bleeding on probing 
CAL Clinical attachment loss
CI Confidence interval 
Cl Chloride 
CPI Community Periodontal Index 
CRP C-reactive protein 
DM Diabetes mellitus
DMF Decayed, missing, filled 
DMFS Decayed, missing, filled surfaces 
ELISA Enzyme-linked immunosorbent assay
FIGO International Federation of Gynecology and Obstetrics 
F.n. Fusobacterium mucleatum 
GDM Gestational diabetes mellitus 
HIV
HMC History of miscarriage
Human immunodeficiency virus
H2PO4
HUCH Helsinki University Central Hospital
Dihydrogen phosphate
IADPSG International Association of Diabetes and Pregnancy Study Groups
IgA/G/M Immunoglobulin A/G/M
IL-1/6 Interleukin-1/6
LBW Low birth weight
MC Miscarriage
Na
NHMC No history of miscarriage
Sodium 
OD Optical density
OGTT Oral glucose tolerance test
OIBI Oral inflammatory burden index
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OIS Oral inflammatory score
OR Odds ratio
P Probability value
PCR Polymerase chain reaction 
PD Probing depth 
P.g. Porphyromonas gingivalis
PGE2 Prostaglandin E
P.i. Prevotella intermedia 
2 
PI Plaque index
PLBW Preterm low birth weight
PMN Polymorphonuclear
PTB Preterm birth
SGA Small for gestational age
SPSS Statistical Package for Social Sciences for Unix
sIgA/G/M Salivary immunoglobulin A/G/M 
SD Standard deviation
T1DM Type 1 diabetes mellitus
TNF- Tumor necrosis factor alpha
WHO World Health Organization
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INTRODUCTION
Preterm birth (PTB), a birth before 37 weeks or 259 days of gestation (WHO 1977, Steer 
2005), causes 75% of perinatal morbidity and mortality and is an important social and health 
problem with a significant economic burden. The prevalence of PTB varies greatly, being 
12.3% of all births in the United States, 5-7% in Europe, and 5.1% in Finland (Goldenberg 
2002, National Institute for Health and Welfare 2010, Klebanoff and Keim 2011). PTBs are 
more prevalent among women with a low socioeconomic status and low education, as well as 
those of black race. Miscarriage (MC), stillbirth, macrosomia, pre-eclampsia, and gestational 
diabetes (GDM) are the other main pregnancy complications.
The role of infection in adverse pregnancy outcomes has been widely investigated, linking 
both generalized and localized infections to PTB, MC, and pre-eclampsia (Friese 2003, 
Michels and Tiu 2007, Conde-Agudelo et al. 2008). Genital infections have been shown to be 
associated with pregnancy complications, and generalized infections, such as pneumonia, may 
expose woman to PTB (Goldenberg et al. 2008). Studies have also shown an association
between periodontal disease and PTB (Offenbacher et al. 1996, Offenbacher et al. 2006, 
Rakoto-Alson et al. 2010, Baskaradoss et al. 2011). Inflamed periodontal tissues contain huge 
amounts of periodontal pathogens, endotoxins, and inflammatory mediators, and this bacterial 
load may affect the welfare of the fetus through bacteremia or result in local and systemic 
inflammatory and immune responses (Offenbacher et al. 1996).
Most of the previous studies have been conducted among multi-racial women with low
socioeconomic status. Thus, we investigated the association between oral health and adverse 
pregnancy outcomes in a group of Finnish women with high education, high socioeconomic 
status, and easy access to health services. Our study hypothesis was that differences exist in 
the oral health status of women with risk pregnancy compared with healthy women with a no-
risk pregnancy.
13
REVIEW OF THE LITERATURE 
Pregnancy
Normal pregnancy lasts 38-42 weeks, concluding in labor in which uterine contractions lead 
to cervical dilation and finally to delivery of the infant. However, many pregnancies are 
complicated either due to pre-existing maternal disease or complications that begin or are first 
recognized during pregnancy. To prevent, detect, and treat these pregnancy problems, it is 
necessary to attend antenatal care. In Finland, almost all (99.8%) pregnant women attend 
antenatal care, and those who do not have an elevated risk of severe adverse pregnancy 
outcome (Raatikainen et al. 2007).
Some of the problems in pregnancy are evident early and with accurate treatment and follow-
up these pregnancies may produce a healthy child, while others may have lifelong 
consequences or may even lead to loss of the baby. Pregnancy is usually divided into three 
parts: first, second, and third trimester. Each of these trimesters has their own special 
characteristics, and each trimester has typical pregnancy problems, e.g. MC is more prevalent 
in the first than in the second trimester (Michels and Tiu 2007).
During pregnancy the maternal body goes through anatomical and physiological changes to 
ensure the welfare of the growing fetus and prepare the mother for delivery. The changes in 
maternal hormone secretion result in metabolic, hemodynamic, and inflammatory alterations 
that support the fetus’ nourishment and development. In the first and second trimesters of 
pregnancy, fetal growth is very limited and nutrients are stored as fat deposits, whereas in the 
third trimester of pregnancy fetal growth is rapid and the transfer of nutrients through the 
placenta is increased (Herrera 2000). The mother also becomes insulin-resistant towards the 
end of pregnancy, and the availability of glucose is increased, facilitating continuous glucose 
transfer to the fetus (Kaaja and Pöyhönen-Alho 2006). Pregnancy is a hypervolemic state 
ensured by activation of the renin-angiotensin system, leading to a 50% increase in plasma 
volume (Kaaja and Greer 2005). The mother is immunosuppressed during pregnancy, 
enabling a genetically incompatible fetus to develop safely without danger of rejection by the 
mother. A thrombophilic state of pregnancy is essential for the hemostatic challenges of 
delivery (Kaaja and Greer 2005). 
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During pregnancy the placenta and ovaries produce increased amounts of both progesterone 
and estrogen. Estrogen maintains pregnancy, is responsible for fetal maturation, and is 
essential for regulating the production of progesterone (Albrecht and Pepe 1999). 
Progesterone, in turn, allows for the development of the endometrium and the prevention of 
contractions. Progesterone has a relaxation effect during pregnancy, and it can reduce 
myometrial estrogen sensitivity. At term, the myometrium becomes more sensitive to estrogen 
through the alteration in the expression rate of the progesterone and estrogen receptors 
(Kamel 2010). 
The factors leading to the initiation of labor remain unclear. However, prostaglandins play a 
role, and prostaglandin E2 can be used to induce labor (Williams et al. 2000). Oxytocin 
stimulates uterine contractions, and the number of oxytocin receptors in the uterus increases 
prior to labor (Williams et al. 2000). The concentration of estrogen increases in relation to 
progesterone, resulting in rising contractility. Spontaneous rupture of the membranes 
generally occurs during labor or at the beginning of labor, with contractions starting after a 
couple of hours. Most women have a vaginal delivery, but in Finland the rate of Cesarean 
sections has increased from 7.9% in 1975 to 17.1% in 2008, and slightly over half of these
were non-elective Cesarean sections (Pallasmaa et al. 2008, National Institute for Health and 
Welfare 2010). 
Pregnancy complications
Preterm birth 
The definition for preterm birth according to the World Health Organization (WHO) and the 
International Federation of Gynecology and Obstetrics (FIGO) is birth before 37 weeks or 
before 259 days of gestation (Table 1) (WHO 1977, Steer 2005). PTB is the most common 
perinatal problem in developed countries (Gibbs 2001, Goldenberg 2002) and is the greatest 
single risk factor for death in the first year of life (Kelly et al. 2006). In Europe, 
approximately 5-7% of all births are preterm, and in Finland the rate is approximately 5.1% 
(Goldenberg 2002, National Institute for Health and Welfare 2010). The survival rate of 
preterm infants has improved, leading to an increase in short-term morbidities such as 
respiratory distress syndrome (Goldenberg et al. 2000, Gibson 2007). The incomplete 
development of organs causes the biggest health problems in the case of PTB, and long-term 
disabilities include lung problems (immature lungs at birth), neurodevelopmental disturbance, 
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behavioral problems, and retinopathy of prematurity (Goldenberg et al. 2000, Steer 2005, 
Gibson 2007, Saigal and Doyle 2008). Overall, PTB inflicts high medical costs through 
neonatal intensive care and treatment of long-term disabilities. 
Of the PTBs, about 5% occur before 28 weeks' gestation and these infants are referred to as 
extremely premature, and 15% occur between 28 and 31 gestational weeks and are referred to 
as severely preterm infants. About 20% of the PTBs occur between 32 and 33 weeks and 
these are known as moderately premature infants, and a further 60-70% occur between 34 and 
36 weeks and are known as near-term infants (Goldenberg et al. 2008). The rate of severe 
neonatal mortality and morbidity is high in the extreme prematurity group, as are severe 
disability and the risk for later behavioral, fine motor, and education difficulties (Wood et al. 
2000). Of the PTBs, 20% are medically induced due to maternal or fetal complications, about 
30% begin with premature rupture of the membranes, and almost 50% begin with 
spontaneous preterm labor (Pararas et al. 2006).
There are many known risk factors for PTB (Table 2). However, the underlying cause is 
generally not obvious. The most significant risk factor is a history of spontaneous preterm 
delivery (Goldenberg et al. 2000). Furthermore, multiple gestation is a common risk factor, 
and in Finland in 2006 altogether 44.6% of twins were born preterm (National Research and 
Development Centre for Welfare and Health 2008). Mercer et al. (1999) showed a 2.5-fold 
increased risk of spontaneous preterm delivery if there was a previous spontaneous preterm 
delivery, and the risk of PTB was inversely associated with gestational age of the previous 
PTB. The rate of PTB is unevenly distributed; among black women it is 16-18%, while 
among white women it is 5-9% (Goldenberg et al. 2008). Further, the risk for a very early 
PTB is several-fold higher in black women than in other racial or ethnic groups (Goldenberg 
et al. 2008). The disparity between black and white women is unexplained. Low 
socioeconomic status and inadequate prenatal care have been shown to increase the risk for 
PTB (Goldenberg 2002, Goldenberg et al. 2008, Debiec et al. 2010). Debiec et al. (2010) 
established that women without prenatal care had an over 7-fold risk of PTB relative to those 
who attended 75-100% of the recommended prenatal care appointments. 
Jolly et al. (2000) revealed that women under 18 years of age were more likely to deliver 
preterm than older women. On the other hand, pregnant women aged 35-40 years were also at 
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increased risk of delivering before 32 weeks of gestation, and women aged >40 years had an 
even higher risk (Jolly et al. 2000, Joseph et al. 2005). Nutritional status affects the rate of 
PTB and studies have indicated that overweight women have a higher risk of delivering 
before 32 weeks of pregnancy (McDonald et al. 2010). In addition, women with a low body 
mass index (BMI) are at risk of delivering preterm, and the rate of PTB has been shown to be 
about 7% in women whose BMI is below 17 (Steer 2005). Maternal illnesses, such as 
hypertension, diabetes, and thyroid disease, are associated with increased risk of preterm 
delivery (Goldenberg et al. 2008, Stagnaro-Green 2009). The definition for cervical 
insufficiency is inability of the uterine cervix to retain pregnancy in the absence of 
contractions or labor. Smoking and use of alcohol during pregnancy have on unfavorable 
effect on birth outcome. Xiong et al. (2009) concluded that the benefit of early smoking 
cessation is clear, and McCovan et al. (2009) showed that severe adverse pregnancy outcomes 
may be reversed if smoking is stopped early in pregnancy. Alcohol use during pregnancy may 
also be a risk factor for preterm delivery (Parazzinin et al. 2003, Aliyu et al. 2010). The study 
of O’Leary et al. (2009) showed an increased likelihood of preterm delivery in women who 
ceased drinking alcohol before the second trimester, but drank alcohol at moderate or higher 
levels in the first trimester.  
There is increasing evidence showing that infection and inflammation might be underlying 
causes of PTB (Goldenberg et al. 2000, Williams et al. 2000, Gibbs 2001, Goldenberg 2002, 
Wei et al. 2010), with up to 40% of PTBs occurring because of infection (Friese 2003). Intra-
uterine infections can result in spontaneous preterm delivery by stimulating uterine 
contractions or membrane rupture (Goldenberg et al. 2000). Histologic examinations of the 
fetal membranes have shown that infection is generally present in PTBs occurring before 30 
weeks of gestation, but rarely in preterm deliveries at 34-36 weeks (Goldenberg et al. 2000). 
Localized infections of the genitourinary tract can lead to PTB, and bacterial vaginosis, an 
imbalance of the microbial ecosystem of the vagina, can increase the rate of PTB by 1.5- to 3-
fold (Leitich et al. 2003, Guaschino et al. 2006). Chlamydia trachomatis and syphilis have 
also been associated with PTB in previous studies (Karinen et al. 2005, Tridapalli et al. 2007, 
Goldenberg et al. 2008). Systemic infections, such as pneumonia, may also be involved in 
PTB (Graves 2010). Moreover, evidence suggests that oral infections, mainly periodontal 
disease, are associated with PTB (Offenbacher et al. 1996). This low-grade infection results in 
local and systemic inflammatory and immune responses, which can be detected in serum.
17
Table 1. Definitions of adverse pregnancy outcomes
Diagnosis Definition
Preterm birth Birth before 37 weeks or before 259 days of gestation
Low birth weight Birth weight less than 2500 g
Miscarriage Pregnancy loss before 22 weeks’ gestation
Stillbirth Fetal death at or after 22 weeks’ gestation
Gestational diabetes Glucose intolerance beginning or first diagnosed during 
pregnancy
Limiting values in oral glucose tolerance test are 0 h 
mmol/L, 1 h 		




Normalized blood glucose within 3 months after delivery
Macrosomia Birth weight > 4000-4500 g at term or weight above the 90th 
percentile or > 2 SD for gestational age
Pre-eclampsia Hypertension (diastolic blood pressure 	


systolic 	

 !"# " $		

24 h) at or after 20 weeks’ gestation
Pregnancy-induced hypertension Hypertension without proteinuria starting at 20 weeks or 
later
Table 2. Risk factors of preterm birth
Maternal factors Obstetrical factors
Young maternal age 
(<18 years) 
Old maternal age 
(>40 years)
History of preterm birth
Increasing number of sexual 
partners (
Low education History of spontaneous
abortion
Smoking > 10 cigarettes
per day
Alcohol use  %#
per day or 7 units/week
History of surgical 
treatment of uterine cervix 
Poor condition of  
chronic disease 
(e.g. hypertension, diabetes)
Infection Uterine abnormalities 
Vaginal bleeding Use of cocaine, amphetamine, 
cannabis
Multiple pregnancy
Pre-eclampsia
Modified from Käypä hoito –suositus, 2011
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Low birth weight (LBW)
The definition of low birth weight is defined as weight less than 2500 g, very low birth 
weight of weight less than 1500 g, and extremely low birth weight as weight less than 1000 g 
(Michalowicz and Durand 2007). The worldwide prevalence of low birth weight (LBW) 
infants is 8-26% (WHO 2005). LBW is often a result of preterm birth and is defined as 
preterm low birth weight (PLBW). The term small for gestational age (SGA) is used if the 
baby weighs below the 10th percentile for gestational age (Williams et al. 2000, Mari and 
Hanif 2007). An infant can be SGA for either constitutional or pathological reasons (Mari and 
Hanif 2007). The underlying cause is maternal disease, such as chronic hypertension or 
diabetes mellitus (DM), which often leads to superimposed pre-eclampsia and placental 
insufficiency and the birth of an SGA baby (Mari and Hanif 2007). 
Miscarriage 
Miscarriage (MC), pregnancy loss before 22 weeks’ gestation, is the most common pregnancy 
complication (Rai and Regan 2006). Of clinically recognized pregnancies, 15% end in MC, 
while 30-50 % of all conceptions miscarry (Rai and Regan 2006, Stephenson and Kutteh 
2007). Sporadic MC affects 25-50% of women, while recurrent MC, the loss of three or more 
consecutive fetuses, affects about 1% of women (Rai and Regan 2006, Stephenson and Kutteh 
2007). The rate of MC decreases as the pregnancy progresses (Michels and Tiu 2007). At least 
50% of first trimester and about 24% of second trimester MCs occur because of chromosome 
abnormalities (Michels and Tiu 2007, Stephenson and Kutteh 2007). High maternal age is one 
of the risk factors for MCs (Nybo Andersen et al. 2000); when age exceeds 40 years, the 
clinical MC rate is as high as 45% (Stephenson and Kutteh 2007). Infections are linked to 
MCs, especially in developing countries (Michels and Tiu 2007). Bacterial vaginosis is a risk 
factor for late MC (Hay et al. 1994, Ugwumadu et al. 2003, Leitich and Kiss 2007), and other 
infections, such as Chlamydia trachomatis, may also lead to MC (Wilkowska-Trojniel et al. 
2009). Other known risk factors are previous spontaneous abortion, multigravidity, smoking 
(Chatenoud et al. 1998), and fetal and maternal structural abnormalities. The risk factors for 
MC are summarized in Table 3.
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Table 3. Risk factors for miscarriage  
Maternal factors Obstetrical factors Fetal factors
Smoking  > 15 cigarettes 
per day
History of miscarriage Chromosomal abnormalities
Heavy alcohol use Uterine abnormalities (e.g. 
cervical incompetence)
Non-chromosomal structural 
abnormalities
Drugs Developmental disorder of 
umbilical cord and placenta
Infections (e.g. chlamydia, 
toxoplasmosis) 
Chronic diseases (e.g. 
hypertension, renal disease)
Old maternal age
(>35 years) 
Trombophilia?
Modified from Naistentaudit ja synnytykset, 2011
Stillbirth
Stillbirth is defined as fetal death at or after 22 weeks of gestation. In Finland in 2010, the rate 
of stillbirths and deaths during the first week of life was 5.8 per 1000 births of all births 
(National Institute for Health and Welfare 2011). Stillbirth is more prevalent in developing 
than developed countries. African-American women have a 2-fold risk of stillbirth relative to 
Caucasian women. This may partly be due to reduced prenatal-care utilization among African-
American women (Vintzileos et al. 2002). It has been hypothesized that differences in medical 
care explain low socioeconomic status as a risk factor for stillbirth (Stephansson et al. 2001). 
Other known risk factors for stillbirth are previous stillbirth, high maternal age, maternal 
obesity, postdate pregnancies, multiple pregnancies, diabetes mellitus, thrombophilia, and 
smoking (Fretts 2005, Smith and Fretts 2007, Flenady et al. 2011). Infection, congenital 
anomalies, abruptio placentae, and umbilical cord accidents may also cause stillbirth. 
However, in nearly 50% of stillbirths the cause remains unclear. 
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Gestational diabetes
Gestational diabetes mellitus (GDM) is defined as glucose intolerance beginning or first 
diagnosed during pregnancy (Kjos and Buchanan 1999). The prevalence of GDM is 1.3-
19.9% depending on diagnostic and screening criteria (Simmons 2011). In Finland, about 
8.5% of pregnant women have GDM (Kaaja and Rönnemaa 2008). GDM is diagnosed by the 
oral 75 g glucose tolerance test (OGTT); the limiting values are 0 h 

		
mmol/L, and 2 h 

&%%" #&
#" %' ##&%   # #
(ADA 2009), two or more of the venous plasma concentrations must be met or exceeded for a 
positive diagnosis. The International Association of Diabetes and Pregnancy Study Groups’ 
(IADPSG) diagnosis criteria for GDM requires that only one of the venous plasma 
concentrations must be met or exceeded; however, these values differ somewhat from the 
ADA values, being 0 h 

		



$(&')*+
2010, O’Sullivan et al. 2011). GDM is associated with many maternal and neonatal 
complications such as macrosomia, pre-eclampsia, Cesarean section, and shoulder dystocia 
(Yogev and Visser 2009). In addition, exposure to elevated blood glucose concentrations 
during pregnancy is associated with increased risk for obesity, metabolic syndrome, and type 
2 diabetes mellitus in adulthood (Simeoni and Barker 2009). However, if GDM is diagnosed 
and treated, these detrimental outcomes can be inhibited or at least relieved. The treatment of 
GDM includes dietary modification, blood-glucose monitoring, and medical therapy (Cheng 
et al. 2008). The risk factors for GDM comprise obesity, family history of diabetes, previous 
GDM, high maternal age, polycystic ovarian syndrome, and previous delivery of a 
macrosomic infant (Ben-Haroush et al. 2003, Haakova et al. 2003). GDM mothers also have 
more pre-pregnancy chronic hypertensive disease than non-GDM mothers, and hypertension 
is related to obesity (Yogev and Visser 2009, Fadl et al. 2010). GDM predicts development of 
maternal type 2 diabetes and metabolic syndrome in the future (Yogev and Visser 2009). 
Macrosomia  
Macrosomia, defined as birth weight > 4000-4500 g at term or above the 90th percentile or > 2 
SD for gestational age, occurs in 45% of diabetic pregnancies (Weindling 2009, Yogev and 
Visser 2009, McGowan and McAuliffe 2010). In addition, women with high gestational 
weight gain are at increased risk of giving birth to a macrosomic infant and sustaining 
macrosomia-related maternal and neonatal morbidities (Hedderson et al. 2006, Stotland et al. 
2006). The number of large infants has been on the rise during the last 2-3 decades, posing 
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problems in obstetrics. Fetal macrosomia increases the risk of maternal and fetal 
complications (Henriksen 2008). Maternal complications include prolonged labor, Cesarean 
section, and perineal injuries (Boulet et al. 2004, Stotland et al. 2004). Fetal short-term 
complications include shoulder dystocia, intrapartal hypoxia, asphyxia, and hypoglycemia 
(Lim et al. 2002), and even fetal death. Studies have also shown an association between 
macrosomia and such long-term health risks as overweight, diabetes, and metabolic syndrome 
(Harder et al. 2007, Voldner et al. 2008).
Pre-eclampsia
Pre-eclampsia complicates 2-8% of pregnancies, and it is the leading cause of maternal as 
well as perinatal mortality and morbidity (Steegers et al. 2010). Pre-eclampsia is defined as 
hypertension (diastolic blood pressure 	

, %!"#"#	


and substantial proteinuria (		
"-#"	.##/-# $*###"#
2010). The pathogenesis of pre-eclampsia is unknown, but the main hypothesis relies on 
defective placental angiogenesis causing disturbed placental function in early pregnancy 
(Steegers et al. 2010). Pre-eclampsia is also characterized by endothelial dysfunction. 
Pregnancy-induced hypertension
Pregnancy-induced hypertension or gestational hypertension is defined as hypertension 
without proteinuria starting at 20 weeks or later. It is estimated that gestational hypertension 
complicates about 5-6% of pregnancies, and this may develop to pre-eclampsia later in 
pregnancy (Roberts et al. 2003, Magee et al. 2009). Studies have shown that mothers with 
overweight assessed by BMI early in pregnancy have a higher risk of pregnancy-induced 
hypertension as well as pre-eclampsia (Sibai et al. 1995, Sibai et al. 1997).
Oral health
Dental caries
The presence of cariogenic bacteria, fermentable carbohydrates, and a susceptible host are 
needed for the development of dental caries (Keyes 1960). Cariogenic bacteria in dental 
biofilm produce organic acids during metabolism of fermentable carbohydrates (Loesche 
1986), and these organic acids dissolve minerals in hard dental tissue. The main groups of 
bacteria needed in the caries process are mutans streptococci and lactobacilli (Featherstone 
2008). Frequent consumption of fermentable carbohydrates increases the amount of these 
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bacteria (Marsh 1994). The progression of dental caries is a dynamic process since periods of 
demineralization and remineralization alternate (Kidd and Fejerskov 2004). Remineralization 
is achievable if fluoride, calcium, and phosphate are present in saliva, and it may completely 
arrest the progression of a lesion (Nyvad et al. 1999). Saliva has good buffering capacity, and 
salivary flow can clear bacteria from the tooth surface. Dental caries is a transmissible 
infectious disease, and the cariogenic bacteria mutans streptococci are usually transmitted to 
young children from their mothers (Alaluusua et al. 1996).
Periodontal disease
Gingiva, alveolar bone, periodontal ligament, and root cementum are the components of 
tooth-supporting tissues attaching the teeth to alveolar bone. The presence of a microbial 
biofilm around the gingival margin is needed for the development of gingivitis, and a local 
inflammatory reaction is achieved by bacterial infection, which in turn activates the innate 
immune system. This activation leads to an expression of pro-inflammatory cytokines, such as 
interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-
prostaglandin E2 (PGE2) (Lee et al. 1995, Offenbacher et al. 1998, Hasegawa et al. 2003), and 
drives the destruction of connective tissue and alveolar bone. Furthermore, it may lead to 
production of C-reactive protein (CRP) from the liver (Pitiphat et al. 2006, Salzberg et al. 
2006). 
Gingivitis is reversible if plaque and calculus are removed, and this interception of gingivitis 
prevents its progression to periodontal disease. Periodontal disease is a chronic oral infection 
where a complex interplay of bacterial infection and host response are responsible for 
destruction of connective tissue and alveolar bone (Oliver et al. 1998). Periodontal disease is 
the most common cause of tooth loss worldwide (Darveau 2010). Periodontal microbiota 
from subgingival plaque sample is often analyzed in the case of progressive periodontal 
disease that does not respond to periodontal treatment. In addition, host response can be 
assessed from gingival crevicular fluid (Lamster 1997). The biofilm and the host 
inflammatory and immune responses vary among individuals, although the clinical 
presentation and diagnostic symptoms are similar (Offenbacher et al. 2007). Dental plaque 
forms naturally on teeth, and in the healthy state the bacterial composition remains relatively 
stable due to a dynamic balance of both synergistic and antagonistic microbial interactions. 
Synergistic microbial interactions include food chains between bacterial species and 
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metabolism of endogenous nutrients, while antagonistic microbial interactions include 
production of bacteriocins and bacteriocin-like substances. In disease, this homeostasis breaks 
down and imbalance of microflora exists (Marsh 1994). The commonly used clinical signs of 
periodontal condition and disease progression include plaque index (PI), bleeding on probing 
(BOP), probing depth (PD), clinical attachment loss (CAL), and radiographic assessment of 
alveolar bone loss (Kaufman and Lamster 2000).
Periodontal microorganisms
Periodontal disease is the clinical result of a complex interaction between host and plaque 
bacteria, and it is polymicrobial, predominantly anaerobic infection. The pathogens involved 
in periodontal disease are Actinobacillus actinomycetemcomitans (A.a.), Porphyromonas 
gingivalis (P.g.), Prevotella intermedia (P.i.), Bacterioides forsythus (B.f.), and 
Fusobacterium mucleatum (F.n.) (Dahlen 1993). A.a. is strongly associated with progressing 
periodontitis (van Wilkelhoff et al. 1992). Periodontal microorganisms involved have certain 
characteristics that contribute to their ability to act as pathogens and participate in tissue 
destruction. First, microorganisms must have the capacity to colonize and survive on the 
ecosystem of the biofilm. Second, pathogens must have the ability to evade antibacterial host 
defense mechanisms that normally control infections though deletion of bacteria. And third, 
the microorganisms must have an ability to initiate tissue destruction directly through self-
produced enzymes (American Academy of Periodontology 1999). For example, P.g. has been 
shown to produce enzymes (proteases, collagenase, fibrinolysin, phopholipase A) that could 
directly degrade surrounding tissues in the superficial layers of the periodontium (Birkedal-
Hansen et al.1988). 
Saliva
Saliva is an important body fluid secreted by minor and major salivary glands. It has a role in 
lubricating oral tissues, participating in oral functions such as swallowing and speaking, and 
protecting oral tissues (Mandel 1987). This protection occurs through killing of 
microorganisms, antiviral activity, and inhibition or neutralization of harmful metabolic 
products by salivary components (Tenovuo 1998, Dawes 2008). There are three pairs of major 
salivary glands: parotid, submandibular, and sublingual, and their ducts open to the second 
maxillary molar, the side of the lingual frenulum, and the lingual sulcus, respectively. Most 
saliva (approximately 90% of total salivary volume) is derived from the major salivary glands 
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(Dawes 2008, Greabu et al. 2009), while about 25% of whole saliva in unstimulated flow 
originates from the parotid, 60% from the submandibular, 7-8% from the sublingual, and 7-
8% from the minor salivary glands. However, when the flow is stimulated, the parotid gland 
secretion increases by 10% (Dawes 2008). Furthermore, the time of day, diet, age, gender, 
many diseases, and medications may affect secretions from the different glands (Greabu et al. 
2009). The minor salivary glands, numbering 600-1000, are located in the labial, buccal, 
lingual, and distopalatal parts of the oral mucosa (Eliasson and Carlén 2010). The secretion of 
saliva is divided into two stages: initial secretion and modification of saliva. The autonomic 
nervous system, both parasympathetic and sympathetic, controls the production of saliva. 
Parasympathetic stimuli increase the secretion of water and electrolytes, and sympathetic 
stimuli enhance the secretion of protein-rich saliva. Saliva is secreted by acinar cells as 
isotonic plasma ultra-filtrate. Saliva is then modified during passage through the ductal cell 
system by reabsorption of sodium (Na+) and chloride (Cl-), resulting in hypotonic secretion 
(Tenovuo 1997). The composition of saliva is about 99% water and ions such as Na+, Cl-, and 
dihydrogen phosphate (H2PO4-), and the ionic composition is derived from plasma. Organic 
components of saliva include urea, glucose, and proteins, such as amylase and glycoproteins, 
all of which have a role in protecting oral cavity tissues (Greabu et al. 2009). 
Salivary antimicrobial systems are divided into immune and non-immune defense factors 
(Kirstilä et al. 1994). Saliva has a protective role in oral health and various roles in the 
digestive tract (Lima et al. 2010). Saliva contains a large amount of proteins; proline-rich 
proteins comprise nearly 70% and amylase most of the remainder of the total protein content 
of human parotid saliva. Many autoimmune, neurologic, and endocrinological diseases 
decrease salivary flow (Tschoppe et al. 2010). The degree of hydration, body position, and 
drug use can affect salivary flow rates (Dawes 2008). 
Salivary immunoglobulins
Salivary immunoglobulin A (sIgA) (> 85%) and immunoglobulin G (sIgG) are the major 
antibodies in saliva, forming 5-15% of total salivary proteins (van Nieuw Amerongen et al. 
2004). Salivary IgA is synthesized by plasma cells in salivary glands, whereas most of the 
IgG in saliva is derived from serum via crevicular fluid, and thus, sIgG represents systemic 
immunity (Brandtzaeg 2007). However, a small part of sIgG may originate from glandular, 
gingival, or tonsillar plasma cells. Salivary IgA is secreted to interstitial fluid and taken up by 
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acinar and ductal cells of the salivary gland, which then secrete sIgA into saliva. 
Immunoglobulins have highly specific binding characteristics, and each immunoglobulin 
idiotype binds and agglutinates specific microbial species. When considering the entire
population of salivary immunoglobulins, they bind the majority of microorganisms present in 
saliva. The main function of salivary immunoglobulins is the inhibition of bacterial adherence 
and colonization (van Nieuw Amerongen et al. 2004). Salivary IgA is considered to be part of 
the first line of defence against pathogens colonizing or invading mucosal surfaces, and it has 
been suggested to be a precise measure of local infection arising in oral mucosa (Seeman et al. 
2004, Janket et al. 2010). Salivary IgA inhibits the adherence of bacteria to mucosal surfaces, 
ablates viruses from mucosal surfaces, and neutralizes toxins and entzymes (McNabb and 
Tomasi 1981, Seeman et al. 2004).
Oral health and pregnancy
Female sex hormones 
Steroid sex hormones are derived from cholesterol, and they are known to affect bone 
integrity through metabolism of bone minerals (Mascarenhas et al. 2003). Estrogen and 
progesterone are the main female sex hormones produced by the ovaries and placenta, and 
they have an important role in physiological changes in women starting from puberty. 
Estrogen and progesterone function synergistically, controlling the menstrual cycle (Amar and 
Chung 1994), and they have important roles in both the maintenance of pregnancy and the 
initiation of labor. During pregnancy estrogen may reach levels 30 times higher and 
progesterone levels 10 times higher than during the menstrual cycle (Amar and Chung 1994, 
Mariotti 1994). Elevated levels of these hormones have a significant influence on different 
organ systems, including the periodontium (Amar and Chung 1994).
Effect of female sex hormones on periodontal tissues
Estrogen and progesterone receptors have been found in gingiva (Vittek et al. 1982, Kawahara 
and Shimazu 2003), and these hormones have been shown to increase vascular permeability 
and the amount of gingival crevicular fluid flow (Mealey and Moritz 2003). In addition, 
estrogen and progesterone may alter the immune system, and progesterone can stimulate the 
production of an inflammatory mediator PGE2 (Mealey and Moritz 2003). Estrogen receptors 
have also been found in periosteal fibroblasts (Aufdemorte and Sheridan 1981) as well as in 
periodontal ligament fibroblasts (Nanba et al. 1989); and thus, the sex hormones may directly 
26
affect these periodontal tissues. In addition, both estrogen and progesterone have been 
demonstrated to have an impact on bone metabolism (Feldman et al. 1975, Erikssen et al. 
1988).
Pregnancy does not cause gingivitis, but may worsen pre-existing disease (Laine 2002). The 
prevalence and severity of gingival inflammation have been shown to increase during 
pregnancy, with these changes disappearing postpartum (Löe and Silness 1963, Tilakaratne et 
al. 2000, Gürsoy et al. 2008). Estrogen and progesterone affect cellular proliferation, 
differentiation, and growth of gingival fibroblasts (Mariotti 1994, Mealey and Mortiz 2003). 
Studies have also revealed that both estrogen and progesterone have a role in bone resorption 
and formation (Lobo et al. 1984, Komm et al. 1988, Gallagher et al. 1991). Susceptibility to 
infections, including periodontal disease, increases during pregnancy, and the underlying 
mechanisms consist of alterations in the immune system (Brabin 1985), hormonal changes, 
limited T-cell activity (Taylor et al. 2002), decreased neutrophil chomotaxis and phagocytosis, 
and depressed antibody production (Zachariasen 1993). Periodontal bacteria P.i. and P.g. can 
use female sex hormones as a source of nutrients, and the amount of these bacteria is 
increased in the gingival crevicular fluid of pregnant women; this correlates positively with 
the severity of pregnancy gingivitis (Kornman and Loeshe 1980). 
Studies have established that pregnant women have more gingival bleeding and inflammation 
than women postpartum; these changes are not associated with the amount of plaque (Löe and 
Silness 1963, Raber-Durlacher et al. 1994). The gingival inflammatory changes begin during 
the second month of pregnancy and increase in severity until the eighth month of pregnancy 
(Löe and Silness 1963, Löe 1965, Tilakaratne et al. 2000). Gürsoy et al. (2008) showed that 
changes in bleeding on probing and periodontal pocket depth increased simultaneously 
without a relation to plaque between the first and second trimesters and then decreased during 
subsequent visits. Thus, these changes were reversible, indicating that pregnancy gingivitis 
does not predispose or proceed to periodontal disease. 
Dental caries during pregnancy
No data indicate that dental caries incidence increases during pregnancy. Development of 
dental caries usually takes several years, and thus, the possible pregnancy-related increase in 
caries incidence is difficult to estimate. In a recent study by Vergnes et al. (2011), dental 
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caries was not significantly associated with preterm birth or preterm premature rupture of 
membranes. Similarly, Durand et al. (2009) found no association between clinical dental 
caries and preterm birth, but low levels of lactobacilli in saliva were associated with preterm 
birth. However, a study by Agueda et al. (2008) linking periodontal disease and preterm birth 
reported a significant association between the presence of untreated caries and preterm birth. 
Oral health and adverse pregnancy outcomes
Periodontal disease and adverse pregnancy outcomes
Oral health, mainly periodontal disease, has been connected to such systemic conditions as 
diabetes, cardiovascular disease, and PTB. Interestingly, pregnancy complications, such as 
pre-eclampsia and gestational diabetes, have also been associated with an increased risk for 
type 2 DM and cardiovascular diseases later in life (Kaaja and Greer 2005). Although the 
association between periodontal disease and adverse pregnancy outcome has been extensively 
investigated, the results have been inconclusive, with a number of studies finding an 
association
The concept of the ability of periodontal pathogens and their virulence factors to disseminate 
and induce both local and systemic inflammatory responses in the host originates from the 
year 1891, when Miller published the theory of “focal infection”. He suggested that focal oral 
infection was responsible for many localized and systemic diseases such as tonsillitis, 
pneumonia, endocarditis, and septicemia. However, because there was no scientific evidence 
supporting this theory, it was put aside for ten decades. In the early 1990s Collins et al. (1994) 
hypothesized that oral infection, such as periodontal disease, could act as a source of bacteria 
and inflammatory mediators that could spread systemically to the fetal-placental unit via the 
blood circulation and induce pregnancy complications. Collins et al. (1994) used the golden 
hamster model to examine the effects of P.g. infection on TNF-PGE
(Jeffcoat et al. 2001, Radnai et al. 2004, Goepfert et al. 2004, Moreu et al. 2005, 
Offenbacher et al. 2006, Siqueira et al. 2007, Guimarães et al. 2010, Vogt et al. 2010, Rakoto-
Alson et al. 2010, Baskaradoss et al. 2011), while others have not (Noack et al. 2005, Moore 
et al. 2005, Bassani et al. 2007, Vettore et al. 2008). Examples of studies of periodontal 
disease and adverse pregnancy outcomes are given in Table 4.
2 inflammatory 
mediator production and pregnancy outcome. A significant association was observed between 
increasing levels of both TNF-PGE2 and fetal growth retardation as well as 
embryolethality. Infections caused by periodontal pathogens were suggested to elicit adverse 
pregnancy outcomes and the degree of PGE2 and TNF- was associated with the severity of 
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fetal effect. Periodontal disease was thus proposed to be a potential independent risk factor for 
adverse pregnancy outcomes. 
The study by Offenbacher et al. (1996) was the first to investigate the link between 
periodontal disease and PTB in humans. The odd ratios were high: 7.9 for all PLBW cases 
and 7.5 for primiparous PLBW cases. Offenbacher and colleagues suggested that periodontal 
infection may serve as a reservoir of bacteria, endotoxins such as lipopolysaccharides, and 
inflammatory mediators such as PGE2 and TNF-. Periodontal disease may affect the welfare 
of the fetus by activating the innate immune system, leading to an increased expression of 
prostaglandins and inflammatory cytokines. C-reactive protein may be the mediator in this 
process, and evidence has emerged that pregnant women with periodontal disease have 
elevated CRP levels early in pregnancy (Horton et al. 2008). The levels of IL-6 and -8 as well 
as of TNF- in maternal serum are associated with PLBW. Hasegawa et al. (2003) examined 
the association between periodontal condition and threatened preterm labor, which often 
results in PTB. They found that women with threatened preterm labor had worsened 
periodontal conditions and elevated serum IL-8 and IL-10 levels compared with control 
women. Dasanayake et al. (2001) also showed that second trimester levels of serum antibody 
against P.g. are related to LBW.
Periodontal pathogens have also been detected in the fetal-placental unit and have been 
demonstrated to colonize directly with the placenta and cause localized inflammatory 
response, resulting in PTB. Katz et al. (2009) used immunocytochemistry methods to identify 
the presence of P.g. antigens in placental tissues. They detected an increase in immunostaining 
intensity of the tissues sectioned from women with chorioamnionitis relative to those 
experiencing full-term pregnancy. These results suggested that P.g. may commonly colonize 
placental tissues and that the presence of this organism may contribute to the preterm delivery. 
Keelan et al. (2010) revealed that periodontal pathogens are capable in eliciting an 
inflammatory response in human decidual cells. 
In the study by Madianos et al. (2001), umbical cord blood samples from 351 infants were 
analyzed. Significantly higher levels of specific IgM against oral pathogens in PTB infants 
were found than in full-term infants. Because maternal IgM does not pass through the 
placental barriers, these results suggest a direct intrauterus fetal exposition to these bacteria, 
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which may have led to premature birth. Boggess et al. (2005) analyzed the umbical cord 
blood samples of 640 infants and measured CRP, IL-10, TNF-, PGE2, 8-isoprostan, and IgM 
levels against the periodontal pathogens P.n, P.i., Fucobacterium nucleatum, 
Peptostreptococcus micros, and Campylobacter rectus. The risk of prematurity was higher 
when IgM was detected against at least one periodontal pathogen and even higher when high 
levels of inflammatory mediators were measured. 
Microorganisms can access the amniotic cavity by ascending from the vagina and the cervix, 
by hematogenous dissemination through the placenta, by accidental introduction during 
invasive procedures, and by reverse spreading through the fallopian tubes (Goldenberg et al. 
2008). The microorganism reaching decidua may stimulate a local inflammatory reaction and 
the production of pro-inflammatory cytokines. In addition, microorganisms may cross intact 
fetal membranes and reach the amniotic cavity, where they can elicit the production of 
inflammatory mediators. Bearfield et al. (2002) showed by polymerase chain reaction (PCR) 
Streptococcus sp. and Fusobacterium nucleatum from amnionic fluid and these 
microorganisms were positively associated with adverse pregnancy outcomes. 
Several studies have examined the effect of periodontal treatment on preterm birth. 
Michalowicz et al. (2006) studied 823 women, 413 of whom had scaling and root planing 
before 21 weeks of gestation and 410 postpartum. No significant differences were found 
between the two groups in birth weight or in the rate of delivery of infants small for 
gestational age. Treatment of periodontal disease during pregnancy was safe and improved the 
periodontal condition, but did not significantly alter the rate of PTB, LBW, or fetal growth 
restriction. In their other study, Michalowicz et al. (2009) observed no significant difference 
between women receiving scaling and root planing before 21 weeks of gestation or after 
delivery. This non-surgical periodontal treatment did not reduce systemic serum markers of 
inflammation.  A randomized controlled trial by Newnham et al. (2009) resulted in similar 
findings, as they noted no differences in PTB, birth weight, pre-eclampsia, or other obstetric 
outcomes between women receiving periodontal treatment around 20 weeks of gestation, 
including mechanical removal of oral biofilms and oral hygiene instruction and motivation, 
and women not receiving this treatment. Likewise, in the study of Oliveira (2011), non-
surgical periodontal treatment during the second trimester of gestation did not reduce the risk 
for PTB, LBW, or PLBW. However, several studies have also described the opposite results, 
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linking periodontal treatment during pregnancy to more favorable pregnancy outcome. A
randomized controlled trial by López et al. (2002) showed that periodontal treatment before 
28 weeks of gestation significantly reduced the rates of PLBW compared with periodontal 
treatment after delivery. Tarrannum and Faizuddin (2007) compared 100 women who received 
non-surgical periodontal therapy during pregnancy with 100 women in the control group who 
received periodontal therapy postpartum. Their results showed that the prevalence of PTB and 
LBW was higher in the women treated postpartum. The prevalence of PTB was 53.5% in the 
women in the treatment group and 76.4% in the control group. In addition, the prevalence of 
LBW was higher in the control group (53.9% vs. 26.3%). These results were supported by the 
findings of Gomes-Filho et al. (2010), who showed that successful periodontal treatment in 
pregnant women with periodontal disease is a protective factor promoting the birth of normal 
birth weight children. In addition, the study of Sant’Ana et al. (2011) revealed that periodontal 
treatment during pregnancy is associated with a decreased risk of developing adverse 
pregnancy outcomes. Jeffcoat et al. (2011) showed that scaling and root planing together with 
oral hygiene instruction was associated with a decreased incidence of spontaneous PTB. 
Interestingly, in this study, 97.7% of the women who had unsuccessful periodontal treatment 
had not seen a dentist for tooth cleaning. 
The meta-analysis of randomized trials by Polyzos et al. (2009) showed that treatment with 
scaling and/or root planing during pregnancy significantly reduces the rate of PTB and may 
reduce the rate of LBW infants. However, after a new meta-analysis of more recent studies, 
Polyzos et al. (2010) concluded that treatment of periodontal disease with scaling and root 
planing cannot be considered an efficient way of reducing the incidence of PTB. However, a
meta-analysis of randomized trials (George et al. 2011) concluded that periodontal treatment 
during pregnancy may reduce PTB and LBW incidence. 
A prospective study by Offenbacher et al. (2006) showed a PTB incidence of 11.2% among 
periodontally healthy women compared with 28.6% in women with moderate to severe 
periodontal disease. Very preterm delivery was 1.8% among women without periodontal 
disease progression compared with 6.4% among women with disease progression. Guimarães 
et al. (2010) observed an association between maternal periodontal disease and preterm as 
well as extreme preterm birth. The study by Goepfert et al. (2004) found an association 
between severe periodontal disease and spontaneous PTB at less than 32 weeks of gestation. 
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Moreu et al. (2005) observed that periodontal disease is a significant risk factor for LBW, but 
not for preterm delivery. Radnai et al. (2004) studied 85 women postpartum and found a 
significant association between PTB and early localized periodontal disease. Also the average 
weight of the infants was lower in the periodontal disease group than in the control group. 
Moreu et al. (2005) noted an association between LBW and percentage of periodontal pockets 
with a depth > 3 mm, suggesting that periodontal disease is a significant risk factor for LBW. 
However, their study did not show any association between periodontal disease and preterm 
delivery. Vogt et al. (2010) examined the association of periodontal disease and adverse 
perinatal outcomes in a group of Brazilian low-risk pregnant women. In this cohort, 
periodontal disease was a risk factor for PTB, LBW, and premature rupture of membranes. 
Studies observing no association between periodontal disease and adverse pregnancy outcome 
include a case-control study by Moore et al. (2005), who examined 154 women postpartum. 
No differences were found in oral hygiene, bleeding on probing, or loss of attachment. 
Similarly, Vettore et al. (2008) investigated the relationship between periodontal disease and 
PLBW by examining 15 measures of periodontal disease. The extent of periodontal disease 
did not increase the risk of PLBW. Bassani et al. (2007) conducted a case-control study 
among 915 women, and periodontal health did not explain negative LBW, PLBW, or intra-
uterine growth restriction. 
Many of the studies examining oral health and pregnancy complications were conducted 
among mothers of low socioeconomic status. Baskaradoss et al. (2011) conducted a case-
control study among 300 women, 100 of whom had undergone spontaneous preterm delivery 
and 200 had delivered full-term. The majority of the women were from a low social class and 
their knowledge of oral health care was poor. A risk of nearly 3-fold for preterm delivery was 
observed in mothers with periodontal disease. A prospective cohort study by Mobeen et al. 
(2008) evaluated the relationship between periodontal disease and birth outcomes in a 
community setting in Pakistan among women, 33% of whom had no education. This study 
showed that periodontal disease was extremely common, and when the severity of periodontal 
disease increased, both the stillbirth and neonatal mortality rates rose.
Only 27% of women in a case-control study by Khader et al. (2009) had an education level 
higher than high school. In this cohort, extent and severity of periodontal diseases were 
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significantly associated with PLBW delivery.  However, when Noack et al. (2005)
investigated 59 pregnant German women, 83% of whom had middle or high socioeconomic 
status, they found no significant differences between women with high risk for PLBW infants 
and control women in any of the periodontal parameters examined.  A retrospective cohort 
study examined 23 441 women of a middle or upper income group who were enrolled  in a 
national insurance plan and who have delivered live births from singleton pregnancies in the 
United States (Albert et al. 2011). Women who received preventive dental care had 
significantly better birth outcomes than those who received no treatment. In addition, Pitiphat 
et al. (2008) examined the effect of periodontal disease on birth outcomes in an insured cohort 
of middle-income women. Their results suggested that periodontal disease is an independent 
risk factor for preterm delivery and/or small for gestational age infants. 
Oral health and miscarriage
Only a few studies have examined the association between oral health and MC. Moore et al. 
(2004) showed a relationship between poor periodontal health and late MC, but no association 
between maternal periodontal disease in the first trimester of pregnancy and PTB or LBW. 
Farrell et al. (2006) demonstrated a weak relationship between poor periodontal health and 
late MC in women who never smoked. 
Oral health and pre-eclampsia
Chronic subclinical infections increase maternal cytokine levels, which may affect vascular 
endothelial function and render pregnant women more prone to the development of pre-
eclampsia. Studies have found an association between periodontal disease and pre-eclampsia. 
Contreras et al. (2006) reported that chronic periodontal disease and the presence of P.g., T.f.,
and Eikenella corrodens were significantly associated with pre-eclampsia. In addition, Nabet 
et al. (2010) showed an association between generalized periodontitis and induced PTB for 
pre-eclampsia, but not with spontaneous PTB or preterm premature rupture of membranes or 
other causes of PTB. Ruma et al. (2008) examined the relationship between maternal 
periodontal disease, maternal systemic inflammation, and the development of pre-eclampsia. 
Women with periodontal disease and systemic inflammation early in pregnancy had an 
increased risk for development of pre-eclampsia. Further, the study by Barak et al. (2007) 
showed a significant presence of periopathogenic microorganisms or their products in 
placentas of women with pre-eclampsia compared with healthy pregnant women. A meta-
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analysis of original research published between 1998 and 2010 revealed that maternal 
periodontal disease has strong associations with pre-eclampsia and prematurity (Matevosyan 
2011). This meta-analysis found that higher rates of tobacco use (RR 3.02), bacterial 
vaginosis (RR 2.7), severe gingivitis (RR 2.47), higher probing depth (OR 2.35), clinical 
attachment level (OR = 2.76), bleeding on probing (RR 1.78), fetal tyrosine kinase (OR 1.6), 
and maternal CRP (OR 3.1) contributed to increased rates of pre-eclampsia (OR 1.68) and 
spontaneous preterm labor (RR 2.75).
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Oral health and gestational diabetes
Several studies have examined the association between periodontal disease and gestational 
diabetes. Xiong et al. (2009) demonstrated that periodontal disease was associated with an 
increased risk of GDM and that a dose-response relationship between an increased risk GDM 
and increasing severity of periodontal disease. In the study by Dasanayake et al. (2008), 
clinical and other periodontal disease-related parameters were collected at least 7 weeks 
before the diagnosis of GDM. No significant association was found between clinical 
periodontal disease and GDM. However, higher vaginal levels of T.f. were significantly 
associated with GDM. Guthmiller et al. (2001) investigated the association of type 1 diabetes 
(T1DM) with the periodontal status of pregnant women. Pregnant women with T1DM 
exhibited greater gingival inflammation and periodontal destruction than non-diabetic 
pregnant women. Likewise, Novak et al. (2006) concluded that women with GDM during 
pregnancy may be at increased risk for developing more severe periodontal disease than 
women without GDM. Chapper et al. (2005) showed that women with GDM and a history of 
pre-gestational obesity had significantly more gingivitis and periodontal attachment loss than 
women with normal pre-gestational BMI. In the study by Ruiz et al. (2011) Brazilian pregnant 
women with diabetes had a significantly higher gingival index, gingival margin location, 
probing depth, clinical attachment level, bleeding on probing, and tooth mobility index than 
non-diabetic pregnant women. The degree of periodontal disease was similar between GDM 
and T1DM. 
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HYPOTHESIS AND AIMS 
General aim and hypothesis
The majority of previous studies on oral health and adverse pregnancy outcomes have been 
carried out among women with a low socioeconomic status and a multi-ethnic background. 
Thus, we set out to investigate the association between oral health and pregnancy 
complications in a group of Finnish women with homogeneous ethnicity and a high 
socioeconomic status. The study hypothesis was that pregnancy complications are reflected in 
the oral health of women, and markers of oral health differ between risk and non-risk subjects. 
Specific aims were as follows: 
1. To compare clinical and microbiological oral health parameters between preterm and full-
term women (Study I).
2. To investigate dental care patterns, i.e. preventive and urgency-based dental treatment, in 
association with the history of miscarriage (Study II). 
3. To examine whether the oral inflammatory burden index, which takes into account 
gingivitis, periodontitis, and oral mucositis, is associated with preterm birth (Study III). 
4. To investigate the association of salivary immunoglobulin-A with diabetes and adverse 
pregnancy outcomes (Study IV).
37
SUBJECTS AND METHODS
This cross-sectional study was approved by the Ethics Committee of the Helsinki University 
Central Hospital (HUCH) (HUS 107/E6/2000, 25.10.2000), as well as the Institutional 
Review Board (TYH 3245 10.2.2003, T1020Y0003 1.12.2006), and registered in the clinical 
investigation register of HUCH at www.hus.fi (64.01.12.2006). The study was conducted 
according to the principles of the Declaration of Helsinki, and all participants provided 
written consent (Declaration of Helsinki 2000). 
Subjects
The study sample included 482 women who gave birth at the Department of Gynecology and 
Obstetrics, HUCH, Finland, between September 2002 and May 2004. Women with problem 
pregnancies are referred to this tertiary referral hospital, leading to a high prevalence of 
women with adverse pregnancy outcomes. The women were randomly recruited in the labor 
ward postpartum and informed about the study. Primary exclusion criteria comprised illicit 
drug abuse and infection with hepatitis B, hepatitis C, or Human immunodeficiency virus
(HIV). In addition, the study was restricted to singleton births. Cohort development in Studies 
I-IV is shown in Figure I.
Comparison groups and assessment of outcomes
Studies I and III
To investigate the association between preterm birth and oral health, the women were 
allocated into two groups according to whether they had delivered before (preterm birth) or 
at/after (full-term birth) 259 gestation days (37 weeks), consistent with the recommendations 
of the World Health Organization (WHO) and the International Federation of Gynaecology 
and Obstetrics (FIGO) (Steer 2005). Gestational age was determined based on the date of the 
last menstrual period and confirmed by ultrasound examination at 11-14 weeks of gestation. 
Among the 328 women, 77 were PTB, while 251 were full-term. 
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Study II
To evaluate the association between MC and oral health, the women were divided into two 
groups according to whether or not they had reported pregnancy loss before 24 weeks of 
gestation in one or more former pregnancies (HMC) (Rai and Regan, 2006); if no pregnancy 
loss was reported, the woman was considered to have no history of miscarriage (NHMC). 
Gestational age was determined, as in Studies I and III, based on the date of the last menstrual 
period and confirmed by ultrasound examination at 11-14 weeks of gestation. Among the 328 
women, 74 had HMC and 254 had NHMC.
Study IV
To assess the association between oral health, diabetes, and adverse birth outcomes, the 
women were allocated into three groups according to whether the diagnosis was gestational 
diabetes, pre-existing diabetes, or no diabetes. Among the 328 women, 42 had gestational 
diabetes, 11 had pre-existing diabetes, and 275 were non-diabetic. 
Clinical examination
A specially equipped dental unit was set up at the hospital. The dental examination of the 
women was performed by two dentists within 2 days postpartum. Both dentists were 
employees of the City of Helsinki Health Department, where monthly education meetings 
served as calibration sessions. If the mother was bedridden, a bedside examination was 
conducted using an otological light source. The two examiners were blinded to pregnancy 
complications. Details of the clinical examinations and analyses are provided in 
Tables 5 and 6.
Dental examination 
Dental status, including caries, fillings, and missing teeth, was recorded. The World Health 
Organization's (WHO) decayed, missing, filled (DMF) tooth and surface indices (DMFS) 
were calculated based on the examination. If any initial (enamel) or dentin caries was 
detected, the tooth was defined as diseased. Third molars were separately recorded. 
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Periodontal examination
A calibrated probe was used to measure periodontal probing depth (PD), the distance from the 
gingival margin to the apical part of the gingival pocket, at six sites per tooth for all teeth. Gingival 
bleeding on probing (BOP) and visible dental plaque were recorded at four sites per tooth for 
all teeth. WHO CPI of Treatment Needs was also recorded according to Ainamo and Bay 
(1975). The severity of periodontal infection was assessed by the number of periodontal 
pockets with probing depth 4 mm and the number of bleeding gingival surfaces. Third 
molars were recorded separately for all periodontal parameters. The presence of pericoronitis 
was defined as bleeding on probing of the third molars.
Mucosal examination
Oral mucosa was systematically examined, and mucosal lesions, such as aphthous ulcers, 
lichen planus, amalgam tattoos, cheek bites, and furred tongue, were registered as yes/no. 
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Table 5. Clinical examination and analyses
Clinical examination Subgingival plaque sampling Salivary analyses
Dental caries
 Tooth indices decayed, 
missing, filled (DMF) 
 Tooth surface indices 
decayed, missing, filled 
(DMFS)
 Presence of initial or 
dentin caries
Periodontal health
 Gingival bleeding on 
probing 
 Visible dental plaque
 Periodontal pocket depth
Oral mucosa
 Aphthous ulcer
 Lichen planus
 Amalgam tattoos
 Cheek bites 
 Furred tongue
Presence of 
 Aggregatibacter 
actinomycetemcomitans
 Porphyromonas 
gingivalis
 Prevotella intermedia
 Prevotella nigrescens
 Treponema denticola
 Tannerella forsythia
Level of 
 Salivary 
immunoglobulin A
 Salivary 
immunoglobulin G
 Salivary 
immunoglobulin M
 Total protein
 Albumin
 Polymorphonuclear 
elastase
Subgingical plaque sampling and analyses
Supragingival plaque was removed with cotton swabs and the tooth surface was dried with 
cotton rolls before collecting subgingival dental plaque with sterile curettes from the 
periodontal pockets of first molars of the first and third jaw quadrants. If the first molar had 
been extracted, the sample was taken from the second premolar or molar from the same jaw 
quadrant. The samples were analyzed with polymerase chain reaction (PCR) for periodontal 
bacteria A.a., P.g., P.i., P.n., T.d., and T.f. (Wahlfors et al. 1995, Meurman et al. 1997). This 
PCR method has been validated and is commonly used in our oral microbiology laboratory.
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Saliva sampling 
The unstimulated and stimulated salivary flow rates were measured. Unstimulated salivary 
flow was measured with the free flowing method and stimulated saliva by 5-min chewing of a 
1-g piece of paraffin wax (Meurman and Rantonen 1994). Samples were then centrifuged for 
4 min at 8000 g at 4ºC and stored at -75ºC to await further analyses.  
Salivary biochemical analyses
The colorimetric Lowry method (Lowry et al. 1951) was used to determine total protein, and 
the immunoturbidometric Tina-Quant® kit (Roche, Basel, Switzerland) to analyze albumin. 
The enzyme-linked immunosorbent assay (ELISA) was applied to determine salivary 
immunoglobulin A, G, and M concentrations. All analyses were performed in duplicate, and 
standards and controls were used.
Salivary elastase analysis
Polymorphonuclear (PMN) elastase activity was analyzed using chromogenic substrate 1 mM 
succinyl-alanyl-alanyl-valine-p-nitroanilide (Sigma Chemicals, St. Louis, MO, USA). A 
spectrophotometer at 405 nm was used to detect the increase of optical density (OD) units 
before and after 1 h of incubation at 37ºC. The difference in the OD values was used as the 
measure of elastase activity (OD405/h).
CRP analyses
Serum samples were taken from the women in the first trimester of pregnancy, and serum 
CRP levels were analyzed from these samples. An immunofluorometric CRP kit was used 
(Innotrac Diag, Turku, Finland). The sensitivity of the assay is 0.05 mg/L, and its assay range 
is 0.05-50 mg/L.
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Table 6. Methods used to analyze plaque, saliva, and serum samples
Measured variable Method
Periodontal pathogen Polymerase chain reaction
Total protein Colorimetric Lowry method
Albumin Immunoturbidometric assay
Salivary immunoglobulin A, G, M Enzyme-linked immunosorbent assay
Polymorphonuclear elastase Spectrophotometer
C-reactive protein Immunofluorometric assay
Maternal characteristics
Questionnaires were used to obtain information about dental care history and health habits, 
oral symptoms, smoking and alcohol use, and general health- and lifestyle-related behavior of 
the women. Medical records were used for information about demographic factors, prenatal 
care, and medical and obstetric history. Chronic diseases and medications were recorded and 
validated against the medical records (validity 97.4%). Pre-pregnancy body mass index (BMI) 
and weight gain between the first and third trimesters were calculated. The number of 
previous pregnancies, including spontaneous miscarriages, PTB, and stillbirths, was also 
recorded from the medical records, as were complications such as infections and pre-
eclampsia. Gestational diabetes was categorized using the simplified White’s classification 
(Study I) (White 1978) and based on the combination of American Diabetes Association 
(ADA) and International Association of Diabetes and Pregnancy Study Groups (IADPSG) 
definitions (Study IV) (IADPSG 2010, O’Sullivan et al. 2011). Pre-existing diabetes was 
determined according to the ADA guidelines (American Diabetes Association 2009). 
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Statistical analyses
Statistical Package for Social Sciences for Unix, SPSS, Chicago, IL, USA (SPSS) was used to 
conduct the univariate analyses. Continuous variables were tested with either t-tests after 
evaluating normality or with non-parametric tests if the data did not fit a normal distribution. 
Categorical data were tested using chi-squared tests or Fisher’s exact test. Multivariate 
analyses were conducted by the logistic regression method using SAS version 9.1 (SAS 
Institute Inc., Cary, NC, USA). Significance levels were set at p = 0.05 (two-tailed) and 
confidence intervals at 95%. Detailed information on the statistical analyses is given in the 
original publications.
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RESULTS
Demographic data (Studies I-IV)
The mean age of the women was 31.1 ± 5.0 years. Of the women, 69.5% were highly 
educated, 22.3% had moderate education, and only 6.4% had no professional education. Most 
of the mothers did not smoke (74.1%) or consume alcohol (73.2%) at all during pregnancy. 
The mean BMI was 23.4 ± 4.2 kg/m2, which is within the normal range, and weight gain 
during pregnancy was 13.4 ± 5.1 kg. Of the women, 18.8% had diagnosed diseases and 10.7% 
had infection during pregnancy, the most common being gynecological infection (6.1%). The 
prevalence of recorded medications was 30.8%, and these were mostly antimicrobial drugs 
(12.3%), which can be considered a proxy of infections. Of the women, 50.0% had given birth 
for the first time. Vaginal delivery was the most common route of delivery (87.8%), while 
7.0% had an elective Cesarean section and 5.2% had an emergency Cesarean section. More 
details of the medical and obstetrical data are presented in Table 7. Of the 328 women, 77 had 
preterm and 251 full-term births (Studies I and III), and 74 had a history of miscarriage, 
while 254 had no history of miscarriage (Study II). Likewise, 42 women had gestational 
diabetes, 11 had diabetes, and 275 had no diabetes diagnosis (Study IV). 
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Table 7. General characteristics and medical and obstetrical data of the women in Studies I 
and III
Parameter All
N = 328
Preterm
N = 77
Full-term
N = 251
P-value
Age, years, mean (SD)
*
31.1 (5.0) 30.9 (5.4) 31.2 (4.9) 0.62
Education %##3$2 228 (69.5) 53 (68.8) 175 (69.7) 0.89
Smoking, N (%)
During pregnancy
Before pregnancy
Not at all
36 (11.0)
49 (14.9)
243 (74.1)
11 (14.3)
7 (9.1)
59 (76.6)
25 (10.0)
42 (16.7)
184 (73.3)
0.30
0.14
0.66
Alcohol consumption during 
pregnancy, N (%)
Not at all
Less than once a month 
Less than once a week
240 (73.2)
64 (19.5)
24 (7.3)
61 (79.2)
9 (11.7)
7 (9.1)
179 (71.3)
55 (21.9)
17 (6.8)
0.19
0.05
0.46
Prepregnancy Body Mass Index, 
kg/m2
23.4 (4.2)
, mean (SD)
23.5 (4.6) 23.4 (4.1) 0.82
Maternal weight gain, kg, mean (SD) 13.4 (5.1) 11.7 (4.8) 13.9 (5.1) <0.01
Primiparity, N (%) 164 (50.0) 50 (64.9) 114 (45.4) <0.01
Maternal diseases, N (%)
Asthma
Diabetes mellitus
60 (18.8)
17 (5.3)
11 (3.4)
17 (23.6)
7 (9.6)
4 (5.2)
43 (17.4)
10 (4.0)
7 (2.8)
0.24
0.08
0.29
Infection during pregnancy, N (%) 35 (10.7) 11 (14.3) 24 (9.6) 0.29
Medication, N (%)
Antimicrobial drugs
101 (30.8)
38 (12.3)
38 (49.4)
18 (24.3)
63 (25.1)
20 (8.5)
<0.001
<0.01
Hospitalization caused by preterm 
contractions, N (%) 13 (4.0) 8 (10.4) 5 (2.0 <0.01
Pre-eclampsia, N (%) 30 (9.1) 8 (10.4) 22 (8.8) 0.66
Cesarean section, N (%)
Emergency Cesarean section, N (%)
23 (7.0)
17 (5.2)
10 (13.0)
11 (14.3)
13 (5.2)
6 (2.4)
<0.05
<0.001
Due to missing values, not all categories have N = 328. 
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Dental health and preterm birth (Studies I, III)
Dental health was uniformly good, and preterm and full-term women had complete dentitions 
(28.9 ± 2.7 vs. 28.7 ± 1.7). Preterm women had more dental caries (93.5%) than full-term 
women (85.3%) (p = 0.06), although not significantly more, when assessed as initial and 
dentin caries in the mouth. No significant difference was observed in DMFS between the 
groups. The results of the oral health parameters are given in Table 8.
Table 8. Oral health parameters of Studies I and III
Parameter Preterm
N = 77
Full-term
N = 251
P-value
Teeth, mean (SD)
*
28.9 (2.7) 28.7 (1.7) 0.75
DMFS, mean (SD) 19.2 (17.7) 19.2 (14.4) 0.97
Prevalence of caries, N (%) 72 (93.5) 214 (85.3) 0.06
Plaque-covered surfaces, mean (SD) 20.4 (20.0) 18.2 (18.1) 0.35
Number of gingival bleeding surfaces
quartile 1 (up to 10 surfaces)
quartile 2 (10< bleeding surface 4
quartile 3 (22< bleeding surfaces4
quartile 4 (33)  
11 (14.7)
27 (36.0)
18 (24.0)
19 (25.3)
62 (25.5)
64 (26.3)
50 (20.6)
67 (27.6)
0.05
0.11
0.53
0.70
Number of > 4 mm periodontal pockets, 
mean (SD) 1.8 (5.9) 1.8 (5.1) 0.98
Oral inflammatory burden, mean (SD)
CPI-based OIBI
Data-driven OIS
1.62 (0.55)
5.47 (2.86)
1.33 (0.66)
4.35 (2.25)
<0.001
<0.01
SD: Standard deviation
DMFS: Decayed, missing, filled surfaces
CPI: Community periodontal index
OIBI: Oral inflammatory burden index
OIS: Oral inflammation score
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Periodontal health and preterm birth (Studies I, III)
None of the individual periodontal parameters showed significant differences between 
preterm and full-term women. Periodontal disease was not a major problem in this study 
cohort, as 75% had less than one site of periodontal pockets 

,- 5#.omen 
had periodontal pocket depth 

6##7
  #"#-!#"  ##
smoking by three-way cross-tabulation, neither appeared to be major risk factors for PTB. 
Because no significant differences were found in any of the separate periodontal parameters, 
the decision to examine the combined effects of many oral infections was made. Thus, oral 
inflammatory burden index (OIBI) (Study III) was constructed based on clinical findings 
(gingival bleeding on probing, probing depth, presence of dental calculus, and potential 
mucositis). Preterm women had significantly higher OIBI and oral inflammation score (OIS) 
values than full-term women (OIBI 1.62 ± 0.55 vs. 1.33 ± 0.66; p = 0.0004; OIS 5.47 ± 2.86 
vs. 4.35 ± 2.25; p = 0.003). 
Periodontal bacteria and preterm birth (Study I)
No significant differences were found in the prevalence of any periodontal bacteria (A.a., P.g.,
P.i., P.n., T.d., and T.f.) analyzed.
Predictors of preterm birth in the regression model (Studies I, III)
Periodontal disease assessed as probing depth of periodontal pockets did not predict preterm 
birth in the regression model in Study I. Low weight gain (<13 kg), antimicrobial treatment, 
and primiparity were the significant predictors in the model. 
In Study III, the multivariate regression model for the preterm birth OIBI was significantly 
associated with PTB (OR = 1.85, 95% CI: 1.10-3.10, p = 0.02). Primiparity (OR = 3.72, 95% 
CI: 1.84-7.52, p = 0.0003), antimicrobial treatment (OR = 4.37, 95% CI: 1.93-9.90,
p = 0.0004), and low weight gain (OR = 1.97, 95% CI: 1.09-3.57, p = 0.03) were other 
significant covariates. OIS was significantly associated with PTB without adjusting for weight 
gain (p = 0.03), but when weight gain was added to the final model, OIS lost its significance 
(p = 0.16). 
Oral health and history of miscarriage (Study II)
The use of urgency-based dental care within 12 months was more prevalent among women 
with a history of miscarriage (HMC) than in women with no history of miscarriage (NHMC) 
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(21.1% vs. 13.1%; p = 0.09). In addition, the HMC and NHMC groups were significantly 
different in terms of age (p < 0.05), antimicrobial treatment (p < 0.05), and infertility 
treatment (p < 0.05). When studying HMC, urgency-based dental treatment showed a 
significant association with HMC (OR = 2.54, 95% CI: 1.21-5.37, p = 0.01) and preventive 
dental treatment showed a marginally significant inverse association (OR = 0.53, 95% CI: 
0.26-1.06, p = 0.07). Self-assessed moderate or poor oral health also revealed an increased 
likelihood of HMC relative to those who reported good or very good oral health (OR = 1.60, 
95% CI: 0.88-2.90, p = 0.12).
Association of salivary immunoglobulin A with diabetes and diabetic sequelae (Study IV)
When comparing control, gestational diabetes, and type 1 diabetes (pre-existing diabetes) 
women, the GDM and control women were significantly different regarding BMI (p < 0.001), 
primiparity (p < 0.01), and serum CRP (p < 0.001), while control and T1DM women were 
significantly different in terms of unstimulated salivary flow (p < 0.01), salivary IgA 
(p < 0.01), and sIgA per mg salivary protein (p < 0.05). Salivary IgA was significantly 
associated with all diabetes in pregnancy, including GDM and T1DM, independent of CRP 
(OR = 1.83, 95% CI: 1.08-3.11, p = 0.02). Furthermore, sIgA normalized by total protein was 
significantly associated with all diabetes (OR = 1.02, 95% CI: 1.00-1.04, p = 0.03). However, 
after excluding women with T1DM, sIgA lost its significant association with gestational 
diabetes (OR = 1.42, 95% CI: 0.80-2.52, p = 0.23), suggesting that sIgA may be associated 
with the immunity-related aspect in diabetes. When age, smoking, and primiparity were 
adjusted, sIgA was highly predictive of T1DM (OR = 4.65, 95% CI: 1.61-13.40, p < 0.01). 
Salivary IgA in all diabetes was significantly associated with macrosomia (OR = 2.34; 95% 
CI 1.23-4.43; p = 0.01). This association also existed when examining women with GDM 
only (OR = 2.40; 95% CI 1.22-4.74; p = 0.01).
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DISCUSSION
We investigated the association of oral health with adverse pregnancy outcome in a cohort of 
Finnish women where many of the confounding factors were already excluded based on the 
study setting. These excluded factors comprised low education, low socioeconomic status, 
and ethnicity. The difficulty in assessing previous studies on this topic arises from the 
different clinical criteria used to define periodontal disease, the different methods used to 
define oral health, the variation in sample sizes, and the different composition of subjects with 
regard to race and socioeconomic status. 
The main finding was that OIBI, a combination of multiple oral infections, was significantly 
associated with PTB, although none of the separate periodontal parameters predicted preterm 
birth. In addition, urgency-based dental treatment was associated with increased risk of HMC, 
while preventive dental treatment was related to a diminished risk of HMC. Self-reported 
poor oral health showed a positive association with miscarriage. Salivary immunglobulin A 
was associated with GDM and T1DM independent of CRP, but when T1DM women were 
excluded, sIgA lost its significance.
Subjects and methods
Participants consisted of 482 women with a high education (69.5% were highly and 22.3% 
moderately educated), high socioeconomic status, and easy access to health services. Most of 
the previous studies concerning oral health and preterm birth have been conducted among 
individuals of multiracial backgrounds (Jeffcoat et al. 2001, Jarjoura et al. 2005, Moore et al. 
2005, Offenbacher et al. 2006, Michalowicz et al. 2006, Siqueira et al. 2007, Vettore et al. 
2008, Newnham et al. 2009, Jeffcoat et al. 2011) or with low socioeconomic status (Mitchell-
Lewis et al. 2001, López et al. 2002, Budunelli et al. 2005, Jarjoura et al. 2005). These are 
factors known to be associated with preterm birth. 
The clinical examination was carried out at the hospital in a specially equipped dental office. 
Because the dental office did not contain dental x-ray apparatus, we were unable to take 
radiographs and diagnose potential periapical lesions. This contributed to the construction of 
the oral inflammatory burden index. However, it is unlikely that many women had periapical 
lesions because no deep caries cavities were detected in the clinical examinations and none of 
the women reported any toothache. 
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Initially, 482 women participated in this cross-sectional study. The clinical examination took 
place within two days postpartum following the example of Offenbacher et al. (1996), who 
conducted clinical examinations within three days postpartum. However, for practical reasons, 
it was impossible to examine all women within two days postpartum, and this led to the 
exclusion of 125 women. In addition, we excluded 25 mothers who delivered twins, and four 
women dropped out for personal reasons. Our final study group thus consisted of 328 women, 
who had all been examined within two days postpartum and had had singleton births. 
Because the dental examination was performed postpartum, no causal relationship between 
oral health and PTB can be concluded. Furthermore, because of the cross-sectional study 
design, we were unable to assess any longitudinal changes in the oral health parameters. 
However, our study design is not uncommon, as several previous studies have examined 
women postpartum (Offenbacher et al. 1996, Davenport et al. 2002, Radnai et al. 2004, 
Budunelli et al. 2005, Jarjoura et al. 2005, Noack et al. 2005, Guimarães et al. 2010).  
Although we did not restrict the age of the women participating, our study cohort did not 
include very young mothers; all mothers were aged between 18 and 44 years. According to 
Jolly et al. (2000), women under 18 years of age are more likely to deliver preterm than older 
women. Our study cohort included women older than 35 years, although earlier studies have 
shown that pregnant women over 35 years have an elevated risk of delivering preterm (Jolly 
et al. 2000, Joseph et al. 2005). The mean age of our study cohort was 31.1 ± 5.0 years; thus, 
most of the women were younger than 35 years, and no significant differences were found in 
age between preterm and full-term women. Furthermore, the average age of primiparous 
women in the greater Helsinki area is 30.0 years, and 25.7% of parturient women are 
years (National Institute for Health and Welfare 2010).
Of the women, 11.0% smoked during pregnancy, with the mean number of daily cigarettes 
being 5. This is somewhat less than the proportion in the Perinatal statistics for the Nordic 
countries, which reported that 14.7% of Finnish women smoked throughout their pregnancy 
in 2008 (National Institute for Health and Welfare 2010). Of the women in the present study, 
73.2% did not use alcohol at all during pregnancy, and most of the women consuming alcohol 
reported drinking less than once a month. Approximately 3-5% of pregnant Finnish women 
drink more than 10 units/week (Halmesmäki 2009). 
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We defined preterm birth as birth before 259 gestation days (37 weeks) in accordance with 
WHO and FIGO (Steer 2005). Up to 10.1% of preterm babies may be misclassified if the 
gestational age is rounded up to gestational weeks (Balchin et al. 2004). At the maximum 7 
days will be misclassified and for intrauterine development these 7 days at this late gestational 
age may make a significant difference.
Regarding oral health parameters, we measured periodontal probing depth, gingival bleeding 
on probing, and teeth with visible dental plaque. The severity of periodontal infection was 
assessed by the mean number of periodontal pockets with a probing depth  4 mm and the 
mean number of gingival bleeding surfaces. Although probing depth is a commonly accepted 
clinical measure of periodontal disease, it uses the gingival margin as a reference point and 
the position of the gingival margin may vary. Thus, using clinical attachment level is more 
precise because the cemento-enamel junction used as a reference point in clinical attachment 
level is stable (Xiong et al. 2007). Noack et al. (2005) used the percentage of sites with 
attachment loss  3 mm based on the American Academy of Periodontology consensus report 
(1999) to describe the severity of periodontal disease, and Rakoto-Alson et al. (2010) used the 
definition of clinical attachment loss  4 mm for at least three sites from different teeth. The 
study by Radnai et al. (2004) combined bleeding on probing and probing depth, as their 
definition for periodontal disease was at least one site of  4 mm probing depth and bleeding 
on probing for 	2-##3#.
%##$		#- #!#"  ##s
the presence of periodontal pockets of  4 mm at  12 probing sites in fully erupted teeth, 
and, together with our study, represents the minority of studies that have not included clinical 
attachment level in the definition of periodontal disease. Some researchers have combined 
probing depth and clinical attachment level, as did Lopez et al. (2002), Siqueira et al. (2007), 
and Agueda et al. (2008), who defined periodontal infection as the presence of four or more 
teeth with one or more sites with probing depth  4 mm and with clinical attachment loss  3
mm at the same site. This variation in definition of periodontal disease leads to biases, as well 
as difficulties in comparing studies. 
Oral health and preterm birth
Nearly all of the women in our cohort had complete dentitions, with a mean of 28.7 ± 2.0 
teeth. Furthermore, none of the women had a history of tooth loss due to poor oral health. 
Examining a mouth with excellent oral health is challenging because the inflammatory burden 
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of separate oral health parameters is low. The impact of dental disease is also difficult to 
assess when the women have hardly any dental disease. Many of the previous studies have 
been performed among women with poor oral health and studies have had wide differences in 
oral health, as for example López et al. (2002) had inclusion criteria > 18 natural teeth, 
Tarannum and Faizuddin (2007) 	%
!##,#"!####7%  "
"
Newnham et al. (2009) 	##
We found no differences in any of the separate periodontal health parameters, i.e. plaque-
covered surfaces, gingival bleeding, > 4 mm periodontal pockets, or prevalence of 
investigated periodontal bacteria. Contrary to our expectations, periodontal health status was 
good and periodontal disease challenge was low in our study cohort, as only five women had 
periodontal pocket depth 

82## #-!%/#


However, many women had gingival bleeding, probably due to pregnancy gingivitis. Our 
findings (Study I) are in agreement with those of Vettore and colleagues (2008), who
examined 15 criteria for periodontal disease based on periodontal pocket depth and clinical 
loss of attachment, and none of these factors appeared to be significant predictors for adverse 
birth outcomes. The study by Noack and colleagues (2005) examining German Caucasian 
women with middle or high socioeconomic status also did not find any significant differences 
in periodontal health parameters between women delivering preterm low birth weight infants 
and control women. 
Because our study cohort had excellent oral health and separate oral health parameters have 
low inflammatory potential alone, the OIBI was constructed to overcome these deficiencies 
(Study III). This index utilized the Community Periodontal Index (CPI) (Ainamo et al. 1982) 
and takes into account the presence of gingivitis, potential mucositis, and periodontal disease; 
it was significantly associated with PTB in this study population. This supports the idea that 
periodontal disease alone might underestimate the total inflammatory burden from the oral 
cavity, and, together with probing depth and clinical attachment levels, studies should assess 
mucosal irritation from calculus deposits and gingival bleeding. In addition to OIBI, 
antimicrobial drug treatment during pregnancy, low weight gain, and primiparity were the 
strongest explanatory factors for PTB. These three explanatory factors are known to be risk 
factors for PTB; thus, this finding was expected. Together with OIBI, we created a data-driven 
OIS. This oral inflammation score included mathematically combined, independently 
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collected data on gingivitis, periodontitis, and oral mucositis from this cohort. The objective 
of this score was to validate CPI’s role as an inflammation burden index. OIS was 
significantly associated with preterm birth, but when weight gain was added to the model the 
association became non-significant. This lack of a significant association with PTB may be 
because of our small study sample. 
The presence of periodontal bacteria was not significantly different between PTB and full-
term groups in our study. Because the women had a low prevalence of deep periodontal 
pockets, it is understandable that no differences in the presence of periodontal bacteria 
between preterm and full-term women existed. However, some previous studies have detected 
higher levels of periodontal pathogens in PLBW mothers than in full-term and normal birth 
weight mothers (Offenbacher et al. 1998, Mitchell-Lewis et al. 2001, Hasegawa et al. 2003).
The study by Mitchell-Lewis et al. (2001) found significantly higher levels of Campylobacter 
rectus and the study by Hasegawa et al. (2003) significantly higher levels of Tannerella 
forsythia in PTB mothers than in full-term mothers. 
When we compared preterm and full-term women concerning dental caries, the prevalence of 
any initial (enamel) and dentin caries was higher in preterm women (93.5% vs. 85.3%, 
p = 0.06). Agueda et al. (2005) found similar results, reporting a significant association
between the presence of untreated caries and PTB in secondary analyses. However, dental 
caries is not expected to trigger any marked systemic inflammatory reactions. 
Previous studies have suggested that in up to 50% of PTBs an infection may be in the 
background (Lockwood 2002). Study III showed that combining the effects of multiple oral 
infections may exceed the threshold for an effect on birth outcome, even though no evident 
periodontal disease existed. Increased bacterial load in oral tissues may affect the welfare of 
the fetus through bacteremia or result in local and systemic inflammatory and immune 
responses (Offenbacher et al. 1996). 
Salivary IgA had a strong relationship with T1DM, an autoimmune disease, but it was not 
associated with GDM. T1DM has an autoimmune background and GDM can be considered to 
be mostly BMI-/obesity-related. In addition, GDM and T1DM have different progression, as 
GDM usually disappears after delivery, while T1DM is a permanent disease. Exaggerated 
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immune response may have a role in the association between salivary IgA and T1DM because 
previous studies have reported that humoral and mucosal immune dysregulation is a causative 
etiology for T1DM (Tenovuo et al. 1986, Ben-Aryeh et al. 1993, Belazi et al. 1998, Iughetti 
1999).
 
Our study is one of the few to have examined the association between oral healthcare patterns 
and history of miscarriage. Moore et al. (2004) showed a relationship between poor 
periodontal health and late miscarriage, but no association between maternal periodontal 
disease in the first trimester of pregnancy and PTB or LBW. Farrell et al. (2006) established a 
weak relationship between poor periodontal health and late miscarriage in women who never 
smoked. Our study revealed that urgency-based dental treatment was positively associated 
with HMC and may be related to the pro-inflammatory response generated by oral infection. 
Poor oral health in HMC women may also be due to the neglect of health issues in general, 
including oral health, after miscarriage. Stephenson and Kutteh (2007) have shown that 
mothers who have had a miscarriage are often depressed, and this may lead to neglect of 
health issues. 
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SUMMARY AND CONCLUSIONS
In our cohort of ethnically and socioeconomically homogeneous Finnish women, periodontal 
health status was uniformly good. No association was found between any specific periodontal 
parameter and adverse pregnancy outcome. However, the combined effects of multiple oral 
infections, as expressed in the OIBI, showed a significant association with preterm birth.  
Data-driven oral inflammation score was also significantly associated with preterm birth, but 
became non-significant after adjusting for weight gain.
Oral healthcare patterns affected birth outcomes in this cohort. Poor dental care patterns were 
positively associated with history of miscarriage, while preventive dental care patterns were 
associated with a lower probability of history of miscarriage. 
Salivary IgA was significantly associated with diabetes in pregnancy and macrosomia, but it 
became non-significant when type 1 diabetes was excluded from the analyses. Thus, sIgA 
may reflect autoimmunity of type 1 diabetes and the general immunity change in pregnancy. 
The results of previous studies concerning oral health and adverse pregnancy outcomes have 
been inconclusive; while some studies have reported an association, others have found no 
association at all. Many studies with a positive association have been conducted among 
African-American women with poor oral health and low socioeconomic status, whereas 
studies conducted among Caucasian women with good oral health and high socioeconomic 
status have failed to show a relationship. When the oral health – adverse pregnancy outcome 
association is examined in a group of women with excellent oral health, the total burden of 
oral inflammation should be assessed instead of only studying separate oral health parameters. 
In conclusion, the combined effects of multiple oral infections may exceed the threshold for 
an effect on birth outcome, even in women without evident oral health problems. Based on the 
findings of this study, all women planning a pregnancy and those who are already pregnant 
should be referred to oral examination and treatment. Pregnant women and those planning 
pregnancy should be counselled for preventive oral care. 
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APPENDIX I
POTILASTIEDOTE
Tutkimuksen nimi: Äidin suun terveydentilan vaikutus raskauden kulkuun, sikiön 
hyvinvointiin sekä lisääntymisterveyden häiriöihin. 
Viimeaikaisissa tutkimuksissa on todetty yhteys äidin infektion ja lapsen alhaisen 
syntymäpainon ja ennenaikaisen synnytyksen välillä. Äidin suun infektiot – etenkin 
hampaiden kiinnityskudossairaudet – voivat olla yksi lisätekijä alhaisen syntymäpainon 
aiheuttajana. 
Olemme tekemässä tutkimusta, jonka tavoitteena on selvittää äidin suun terveyden vaikutus 
raskauden kulkuun ja sikiön hyvinvointiin. Tutkimuksen kohderyhmä ovat äidit, jotka 
synnyttävät Naistenklinikalla vuosien 2002 – 2003 aikana. Tutkimukseen osallistuu 450 äitiä. 
Hammaslääkäri tekee äidille monipuolisen ja normaalia perusteellisemman suun ja 
hampaiston tutkimuksen synnytyksen jälkeen. Äidiltä otetaan myös sylki- ja ientaskunäyte. 
Samassa yhteydessä tehdään haastattelu suunhoitotottumuksista ja aikaisemmasta 
hammashoidosta. Taustatiedot, odotusaikaan ja synnytykseen liittyvät tiedot saadaan 
äitiyskortista ja potilasasiakirjoista. 
Tutkimukseen osallistuminen on vapaaehtoista ja sen voi keskeyttää missä vaiheessa tahansa 
syytä ilmoittamatta. Tutkimukseen osallistuminen tai siitä kieltäytyminen ei mitenkään 
vaikuta Naistenklinikalla annettavaan hoitoon.
Tutkimusraportissa ei ole yksilöitävissä tutkimukseen osallistunutta henkilöä. Tutkimuksessa 
syntyvä, yksittäistä henkilöä koskeva tutkimusmateriaali hävitetään tai arkistoidaan 
henkilötietolain edellyttämällä tavalla. 
Lisätietoja antaa tutkimushoitaja Anneli Sinkkonen, puh. 62560
Tutkija: Hammaslääkäri Aura Heimonen
Helsingin terveysvirasto
Keskinen terveyskeskus
puh. 310 50679
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SUOSTUMUS
Tutkimuksen nimi: Äidin suun terveydentilan vaikutus raskauden kulkuun, sikiön 
hyvinvointiin sekä lisääntymisterveydenhäiriöihin. 
Olen saanut suullisesti ja kirjallisesti selvityksen oikeuksistani, tutkimuksen tarkoituksesta ja 
siinä käytettävistä menetelmistä.
Suostun minulle tehtävään suun ja hampaiston tutkimukseen ja annan luvan käyttää 
äitiyskortin ja potilasasiakirjojen tietoja tutkimustarkoituksiin. 
Helsinki_____/_____ 2002
_______________________________          _______________________________
Tutkimushenkilön allekirjoitus ja Suostumuksen vastaanottajan allekirjoitus 
nimenselvennys ja nimenselvennys     
_______________________________
Henkilötunnus
_______________________________
Osoite
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APPENDIX II
TUTKIMUS: Äidin suun terveydentilan vaikutus raskauden kulkuun, sikiön hyvinvointiin 
sekä lisääntymisterveydenhäiriöihin
Terveydenhoitajan täyttämä haastattelulomake
HAASTATTELIJAN TIEDOT
1. Haastattelijan 
nimi____________________________________________________________
2. Sairaalan nimi ja osoite
3. Sairaalan puhelinnumero
4. Haastattelu koskee 1. tapausta
2. verrokkia
5. Tutkimusnumero
ÄIDIN TIEDOT
6. Äidin sukunimi
7. Äidin etunimet
8. Äidin tämänhetkinen osoite
9. Äidin kotiosoite
10. Äidin puhelinnumero
11. Äidin kotikunta
12. Äidin henkilötunnus
13. Äidin ammatti 
14. Lapsen isän ammatti
15. Lääkkeiden käyttö raskauden aikana
ei kyllä ei tietoa
särky- ja kuumelääkkeet
antibiootit, sulfat
lääkkeet gynekologisiin tulehduksiin
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TIEDOT LAPSESTA
16. Lapsen sukupuoli 1. tyttö 2. poika 3. epäselvä
17. Lapsen tila syntymän jälkeen 1. elävänä syntynyt
2. kuolleena syntynyt
18. Mikä oli lapsen syntymäpaino__________g ei tietoa
pituus __________cm ei tietoa
19. Montako Apgar pistettä lapsi sai 10 minuutin kuluttua synnytyksestä
__________pistettä ei tietoa
TIEDOT SYNNYTYKSESTÄ
20. Äidin siviilisääty 1. naimisissa tai avoliitossa
2. naimaton
3. eronnut
4. leski
21. Äidin ammattikoulutus 1. ei ammattikoulutusta
2. ammattikoulu
3. työpaikkakoulutus
4. opistotasoinen koulutus
5. korkeakoulututkinto
6. muu, mikä ___________________
22. Kuinka kauan raskaus kesti________vko
23. Montako lasta syntyi
24. Lapsiveden määrä
25. Mikä oli painonne 
a) raskauden alussa  ________kg ei tietoa
b) ennen synnytystä ________kg ei tietoa
26. Mikä on pituutenne
27. Mikä on Rh-veriryhmänne Rh+ Rh- ei tietoa
28. Kuinka monta kertaa kävitte äitiysneuvolassa raskauden aikana
1. alle 6 kertaa
2. yli 6 kertaa
3. ei tietoa
29. Onko teillä ollut ennen tätä raskautta jokin seuraavista tiloista ja kuinka monta kertaa
ei kyllä lkm ei tietoa
keskenmeno
kohdun ulkoinen raskaus
keskosynnytys
kuolleena syntynyt
lapsi
30. Monesko raskaus tämä on (luetaan mukaan kaikki raskaudet, keskenmenot, raskauden-
keskeytykset, kohdun ulkoiset raskauden ja synnytykset) ja meneillään oleva raskaus
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31. Monesko synnytys tämä on (mukaan lukien kaikki aikaisemmat synnytykset)
TIEDOT ÄIDIN SAIRAUKSISTA
32. Oliko teillä raskausaikana tai synnytyksen jälkeen jokin seuraavista sairauksista tai 
oireista ei kyllä ei tietoa
1. supistelujen vuoksi sairaalahoito
2. infektio raskauden, synnytyksen ja/tai 
postpartaalivaiheen aikana
3. laskimotulppa/keuhkoveritulppa raskauden,
synnytyksen ja/tai postpartaalivaiheen aikana
4. istukan tauti: äiti terve ennen 20 rv: hypertensiivinen
raskaus rr yli 140/90 mmhg 20 rv jälkeen
5. rr nousu (rr yli 140/90 mmhg) ja proteinuria (pre-eklampsia)
6. diabetes
7. verenpainetauti
8. munuaistauti
9. oligohydramnion, afi alle 5 
10. polyhydramnion, afi yli 25
11. apgar-pisteet 7 tai alle 7
12. poikkeava vuoto (alatiesynn. yli 500 ml, sektio yli 1000 ml)
13. napanuorakomplikaatio
14. sikiön virheellinen tarjonta ja siitä johtuvat komplikaatiot
15. kiireellinen/hätäsektio
16. lapsivesi-infektio
17. ennenaikainen synnytys, ennen 37 rv
18. äiti terve: kasvuhidastuma yksinään
19. sikiön epämuodostuma
20. vastasyntyneen infektio
21. synnytysvaurio
22. sikiön kuolema 
TIEDOT JOISTAKIN ÄIDIN ELÄMÄNTAVOISTA ODOTUSAIKANA
33. Tupakoitteko
1. kyllä 
2. ei 
3. aiemmin, olen lopettanut…….vuotta sitten
34. Jos kyllä, niin
1. päivittäin, noin…….tupakkaa
2. säännöllisesti, mutta ei päivittäin
3. satunnaisesti
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35. Alkoholin käyttö raskauden aikana
1. ei lainkaan
2. harvemmin kuin kerran kuukaudessa
3. harvemmin kuin kerran viikossa
4. harvemmin kuin päivittäin
5. päivittäin
36. Huumeiden käyttö
1. ei lainkaan
2. olen käyttänyt huumeita
TUTKIMUS: Äidin suun terveydentilan vaikutus raskauden kulkuun, sikiön hyvinvointiin 
sekä lisääntymisterveyden häiriöihin.
HAMMASHOITOTOTTUMUKSIA KARTOITTAVA HAASTATTELULOMAKE
1. Koska kävitte viimeksi hammaslääkärissä
1. alle ½ vuotta sitten
2. ½-1 vuosi sitten
3. 1-2 vuotta sitten
4. yli kaksi vuotta sitten
5. ei koskaan
2. Miten päädyitte hammaslääkärin hoitoon
1. hammaslääkäri kutsui minut hoitoon
2. terveydenhoitaja lähetti hoitoon
3. otin itse yhteyttä hammashoitolaan
4. lääkäri lähetti minut hammaslääkärin hoitoon
3. Mikä oli viimeinen hammashoitopaikkanne
1. yksityishammaslääkäri
2. terveyskeskushammaslääkäri
3. työterveyshuollon hammaslääkäri
4. Onko viimeisen hoitosarjan yhteydessä
1. tarkastettu hampaat
2. paikattu hampaita
3. hoidettu iensairautta
4. opetettu hampaiden puhdistamista tai muuta ehkäisevää hoitoa
5. tehty proteettinen työ
6. muita toimenpiteitä
5. Miten arvioitte hampaittenne kuntoa tällä hetkellä
1. hyvä
2. melko hyvä
3. keskitasoinen
4. melko huono
5. huono 
6. en osaa sanoa
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6. Kun puhdistat hampaasi, millä sen yleensä teet
(voi olla useampia vaihtoehtoja)
1. tavallisella hammasharjalla
2. sähköhammasharjalla
3. hammaslangalla ja/tai hammastikulla
4. muu, mikä______________________
7. Onko teillä ollut mielestänne odotusaikana tavallista enemmän ienverenvuotoa
1. kyllä
2. ei 
3. en osaa sanoa
8. Kuinka usein harjaatte hampaanne
1. ei koskaan
2. harvemmin kuin joka toinen päivä
3. joka toinen päivä
4. kerran päivässä
5. useammin kuin kerran päivässä
9. Suun tuntemukset
Onko teillä esiintynyt suun alueella raskauden aikana
1. kielen kirvelyä
2. suun poltetta
3. limakalvokipua
4. suun kuivumista
TIEDOT JOISTAKIN ÄIDIN ELINTAVOISTA ODOTUSAIKANA
10. Tupakoitteko 
1. kyllä 
2. ei
3. aiemmin, olen lopettanut…….vuotta sitten
11. Jos kyllä, niin
1. päivittäin, noin……..tupakkaa
2. säännöllisesti, mutta ei päivittäin
3. satunnaisesti
12. Alkoholin käyttö raskauden aikana
1. ei lainkaan
2. harvemmin kuin kerran kuukaudessa
3. harvemmin kuin kerran viikossa
4. harvemmin kuin päivittäin
5. päivittäin
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TUTKIMUSLOMAKE
Tutkimus: Äidin suun terveydentilan vaikutus raskauden kulkuun, sikiön hyvinvointiin sekä 
lisääntymisterveydenhäiriöihin
Nro________________ Pvm/tutkija___________________________________
1. Aikaisempi hammashoito: säännöllistä ( ) terveyskeskuksessa ( )
vain tarvittaessa ( ) yksityishammaslääkäri ( )
hammasteknikko ( )
2. Plakkitutkimukset: pvm_______ näytteenottohampaat_______
B. forsythus  _______
P. gingivalis  _______
P. intermedia _______
A. actinomyc._______
3. Status
8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8
4. Kariesindeksit DMF_______ DMFS_______ DS_______ juurikaries_______
5. Proteesit: yläleuka___________________ (1= kyllä, 2 = ei)
alaleuka ___________________
6. Purentalihakset (1 = ok, 2 = muutos) ________________________________
Potilaan nimi/adreematarra
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